180 related articles for article (PubMed ID: 29637743)
21. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
[TBL] [Abstract][Full Text] [Related]
22. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices.
Cholankeril G; Yoo ER; Perumpail RB; Younossi ZM; Ahmed A
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):313-315. PubMed ID: 27609705
[No Abstract] [Full Text] [Related]
23. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
Bernardi M; Gitto S; Biselli M
J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
[TBL] [Abstract][Full Text] [Related]
24. Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.
; ; ; Bolondi L; Cillo U; Colombo M; Craxì A; Farinati F; Giannini EG; Golfieri R; Levrero M; Pinna AD; Piscaglia F; Raimondo G; Trevisani F; Bruno R; Caraceni P; Ciancio A; Coco B; Fraquelli M; Rendina M; Squadrito G; Toniutto P
Dig Liver Dis; 2013 Sep; 45(9):712-23. PubMed ID: 23769756
[TBL] [Abstract][Full Text] [Related]
25. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
[TBL] [Abstract][Full Text] [Related]
26. [Liver transplant indication and waiting list inclusion].
Husová L
Vnitr Lek; 2013 Aug; 59(8):658-62. PubMed ID: 24007218
[TBL] [Abstract][Full Text] [Related]
27. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
[TBL] [Abstract][Full Text] [Related]
28. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Liver Transpl; 2018 Oct; 24(10):1346-1356. PubMed ID: 30067889
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
30. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States.
Heimbach JK; Hirose R; Stock PG; Schladt DP; Xiong H; Liu J; Olthoff KM; Harper A; Snyder JJ; Israni AK; Kasiske BL; Kim WR
Hepatology; 2015 May; 61(5):1643-50. PubMed ID: 25644186
[TBL] [Abstract][Full Text] [Related]
31. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF).
;
Dig Liver Dis; 2016 Aug; 48(8):860-8. PubMed ID: 27267817
[TBL] [Abstract][Full Text] [Related]
32. Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates.
Alver SK; Lorenz DJ; Marvin MR; Brock GN
Liver Transpl; 2016 Oct; 22(10):1343-55. PubMed ID: 27343202
[TBL] [Abstract][Full Text] [Related]
33. A new liver transplant priority for patients with hepatocellular carcinoma.
Ravaioli M; Grazi GL; Vetrone G; Kimura T; Zanello M; Ercolani G; Cescon M; Varotti G; Del Gaudio M; Tuci F; Cucchetti A; La Barba G; Vivarelli M; Lauro A; Ramacciato G; Pinna AD
Hepatogastroenterology; 2008; 55(86-87):1742-5. PubMed ID: 19102382
[TBL] [Abstract][Full Text] [Related]
34. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions, and more.
Kalra A; Wedd JP; Biggins SW
Curr Opin Organ Transplant; 2016 Apr; 21(2):120-6. PubMed ID: 26825358
[TBL] [Abstract][Full Text] [Related]
35. Pro (With Caution): Extended oncologic indications in liver transplantation.
Mazzaferro V; Battiston C; Sposito C
Liver Transpl; 2018 Jan; 24(1):98-103. PubMed ID: 29077253
[TBL] [Abstract][Full Text] [Related]
36. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
[TBL] [Abstract][Full Text] [Related]
37. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.
Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M
J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of liver grafts from living donors into adults.
Shaked A; Lucey MR
N Engl J Med; 2001 Sep; 345(12):923-4. PubMed ID: 11565532
[No Abstract] [Full Text] [Related]
39. Management of hepatocellular carcinoma in the waiting list before liver transplantation.
Majno P; Giostra E; Morel P; Hadengue A; Mentha G;
J Hepatol; 2005; 42 Suppl(1):S134-43. PubMed ID: 15858867
[No Abstract] [Full Text] [Related]
40. Feasibility of using marginal liver grafts in living donor liver transplantation.
Lan X; Zhang H; Li HY; Chen KF; Liu F; Wei YG; Li B
World J Gastroenterol; 2018 Jun; 24(23):2441-2456. PubMed ID: 29930466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
